3NCZ
X-Ray Co-structure of Rho-Associated Protein Kinase (ROCK1) with a potent 2H-isoquinolin-1-one inhibitor
Summary for 3NCZ
Entry DOI | 10.2210/pdb3ncz/pdb |
Related | 3NDM |
Descriptor | Rho-associated protein kinase 1, cis-4-amino-N-(7-chloro-1-oxo-1,2-dihydroisoquinolin-6-yl)cyclohexanecarboxamide (3 entities in total) |
Functional Keywords | rho kinase, dimer, phosphorylation, transferase, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 4 |
Total formula weight | 193328.28 |
Authors | |
Primary citation | Ginn, J.D.,Bosanac, T.,Chen, R.,Cywin, C.,Hickey, E.,Kashem, M.,Kerr, S.,Kugler, S.,Li, X.,Prokopowicz, A.,Schlyer, S.,Smith, J.D.,Turner, M.R.,Wu, F.,Young, E.R. Substituted 2H-isoquinolin-1-ones as potent Rho-kinase inhibitors: Part 2, optimization for blood pressure reduction in spontaneously hypertensive rats. Bioorg.Med.Chem.Lett., 20:5153-5156, 2010 Cited by PubMed Abstract: Phenylglycine substituted isoquinolones 1 and 2 have previously been described as potent dual ROCK1/ROCK2 inhibitors. Here we describe the further SAR of this series to improve metabolic stability and rat oral exposure. Piperidine analog 20 which demonstrates sustained blood pressure normalization in an SHR blood pressure reduction model was identified through this effort. PubMed: 20678931DOI: 10.1016/j.bmcl.2010.07.014 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (3 Å) |
Structure validation
Download full validation report